Relative efficiency of chlamydia screening in non-clinical settings in two California counties

International Journal of STD and AIDS

Volumn 21, Issue 1, 2010, Pages 52-56

  Morris, S R ^a   Bauer, H M ^a   Chartier, M ^a   Howard, H ^a   Watson, S ^a   Yokotobi, J ^b   Taylor, A F ^c   Bolan, G ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b Stanislaus County Health Services Agency   (United States)

^c San Bernardino County Department of Public Health   (United States)

Author keywords

Chlamydia; Cost effectiveness; Non clinical sites; Screening; STD

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HUMAN; INCIDENCE; JUVENILE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; SCHOOL; SCHOOL CHILD; SCREENING; UNITED STATES;

ADOLESCENT; ADULT; CALIFORNIA; CHILD; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; PREVALENCE; YOUNG ADULT;

EID: 75149150401     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.008474     Document Type: Article

References (20)

1. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004;291:2229-36
2. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007;147:89-96
3. Rein DB, Kassler WJ, Irwin KL, Rabiee L. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet Gynecol 2000;95:397-402
4. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006;55:1-94
5. Meyers DS, Halvorson H, Luckhaupt S. Screening for chlamydial infection: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2007;147:135-42
6. Roberts TE, Robinson S, Barton P, Bryan S, Low N. Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling. Sex Transm Infect 2006;82:193-200; discussion 201
7. Geisler WM, Chyu L, Kusunoki Y, Upchurch DM, Hook EW III. Health insurance coverage, health care-seeking behaviors, and genital chlamydial infection prevalence in sexually active young adults. Sex Transm Dis 2006;33:389-96
8. Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans - United States, 1999-2001. MMWR 2004;53:983-5
9. Hoover K, Tao G, Kent C. Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics. Obstet Gynecol 2008;112:891-8
10. Ford CA, Viadro CI, Miller WC. Testing for chlamydial and gonorrheal infections outside of clinic settings: a summary of the literature. Sex Transm Dis 2004;31:38-51
11. Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 2004;9:197-204
12. Cameron AC, Trivedi PK. Econometric models based on count data: comparisons and applications of some estimators. J Appl Econom 1986;1: 29-53
13. Howell MR, Quinn TC, Brathwaite W, Gaydos CA. Screening women for Chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis 1998;25:108-17
14. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med 1998;128:277-84
15. Bauer HM, Chartier M, Kessell E, et al. Chlamydia screening of youth and young adults in non-clinical settings throughout California. Sex Transm Dis 2004;31:409-14
16. Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 1997;127:796-803
17. Mertz KJ, Schwebke JR, Gaydos CA, Beidinger HA, Tulloch SD, Levine WC. Screening women in jails for chlamydial and gonococcal infection using urine tests: feasibility, acceptability, prevalence, and treatment rates. Sex Transm Dis 2002;29:271-6
18. Liebschutz JM, Finley EP, Braslins PG, Christiansen D, Horton NJ, Samet JH. Screening for sexually transmitted infections in substance abuse treatment programs. Drug Alcohol Depend 2003;70:93-9
19. Kent CK, Branzuela A, Fischer L, Bascom T, Klausner JD. Chlamydia and gonorrhea screening in San Francisco high schools. Sex Transm Dis 2002;29:373-5
20. Jones CA, Knaup RC, Hayes M, Stoner BP. Urine screening for gonococcal and chlamydial infections at community-based organizations in a high-morbidity area. Sex Transm Dis 2000;27:146-51